Rhythm Pharmaceuticals, Inc.
METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS
Last updated:
Abstract:
The disclosure is related to a method of treating a disorder, such as obesity or a condition associated with obesity, such as hyperphagia, in a subject using a melanocortin-4 receptor (MC4R) agonist.
Status:
Application
Type:
Utility
Filling date:
4 Apr 2022
Issue date:
21 Jul 2022